Research SquareFebruary 13, 2025Ayanna K. Bell, Bianca R. Watt, Arturo S. Lopez Flores et al.1 citation
preprint
Abstract Background Cultural biases within healthcare systems result in inequitable treatment, harms, and mistrust—particularly for individuals with marginalized identities. Cultural humility training is dynamic, reflective, and emphasizes person-centered care and mutual respect. Psychedelic-assisted therapy (PAT) is an emerging modality for treating psychiatric disorders. Practice manuals and...
Psychedelic-assisted therapy for mental health conditions is being researched in clinical trials. There are associated benefits, risks and policy considerations.
Methamphetamine use disorder is a significant public health concern. No pharmacological treatment options currently exist for methamphetamine use disorder, and psychotherapy is only moderately effective. Preliminary evidence suggests that ketamine-assisted psychotherapy produces sustained improvements in substance use and mental health symptomatology. In addition to direct antidepressant...
There is notable controversy about the role of psychotherapy in clinical trials of psychedelic-assisted therapy (PAT). This heated and perpetually evolving debate informs questions such as how much therapy should accompany a psychedelic intervention (Marseille et al. , 2022), what type of therapy most effectively complements psychedelic administration (Cavarra et al. , 2022;Yaden et al. ,...
Objective: To assess the viewpoints of psychedelic practitioners in research settings on approaches to psychological support for psychedelic treatments. Methods: An anonymous survey was distributed via email to contacts listed on ClinicalTrials.gov for clinical trials of psilocybin and LSD, personal contacts of authors, and through snowball sampling. The survey included Likert type, multiple...
There is a mental health crisis affecting youth, and the utility of existing treatments is often limited by lack of effectiveness and tolerability. The aim of this review is to report on outcomes of clinical trials for psilocybin-assisted psychotherapy for adults with depression and MDMA-assisted psychotherapy for adults with post-traumatic stress disorder (PTSD) and discuss recommendations for...
Psychedelic-Assisted Therapy (PAT) is gaining traction as a novel approach to addressing the psychological and existential distress experienced by patients. This systematic review aimed to investigate the impact of PAT on spirituality, mystical experiences, and spiritual well-being (SpWB) in patients with life-threatening, incurable, or terminal illnesses. A comprehensive search was conducted...
• A 60-year-old man with recurrent depression and history of delusions died after psilocybin-assisted therapy. • Psilocybin-triggered delusions and emotional dysregulation may have contributed. • Weak therapeutic alliance hindered assessment of patient's internal state. • Delusional symptoms may contraindicate psychedelic interventions. • This case emphasizes the need for thorough assessment...
Context: Psychiatric and existential distress are common and difficult-to-treat symptoms that are frequently encountered in the palliative care setting; current treatment options are limited in efficacy and tolerability. Psychedelic-assisted therapies (PAT) have gained public and scientific interest in their potential to induce rapid and effective reductions in psychiatric and existential...
This paper presents insights from the Psychedelic Therapists Diversity (PTD) study, a qualitative study conducted to understand how BIPOC therapists perceive psychedelic therapy and research. The inciting incident for this research occurred during our collaboration on a clinical trial of psilocybin-assisted therapy for depression in cancer patients.1 Candace Oglesby was the only therapist of...